Showing results (761-770 of 1,033) with videos related to

Sort By:
Pageof 104
The Lancet. Respiratory Medicine|January 6, 2024
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trialAritoshi Hattori, Kenji Suzuki, Kazuya Takamochi, et al.
The Lancet. Respiratory Medicine|January 6, 2024
Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trialEvangelos J Giamarellos-Bourboulis, Athanasios Siampanos, Amalia Bolanou, et al.
The Lancet. Respiratory Medicine|December 17, 2023
High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus studySujal R Desai, Nishanth Sivarasan, Kerri A Johannson, et al.
The Lancet. Respiratory Medicine|December 3, 2023
Balanced crystalloids versus saline for critically ill patients (BEST-Living): a systematic review and individual patient data meta-analysisFernando G Zampieri, Alexandre B Cavalcanti, Gian Luca Di Tanna, et al.
The Lancet. Respiratory Medicine|February 4, 2024
Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trialNicholas Heming, Alain Renault, Emmanuelle Kuperminc, et al.
The Lancet. Respiratory Medicine|May 13, 2024
Leveraging the pleural space for anticancer therapies in pleural mesotheliomaKevin G Blyth, Prasad S Adusumilli, Philippe Astoul, et al.
The Lancet. Respiratory Medicine|May 13, 2024
Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trialEric Lim, David Waller, Kelvin Lau, et al.
The Lancet. Respiratory Medicine|May 27, 2024
When to intubate in acute hypoxaemic respiratory failure? Options and opportunities for evidence-informed decision making in the intensive care unitKevin G Lee, Oriol Roca, Jonathan D Casey, et al.
The Lancet. Respiratory Medicine|May 5, 2024
Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trialRobert P Frantz, Vallerie V McLaughlin, Sandeep Sahay, et al.
The Lancet. Respiratory Medicine|September 22, 2024
Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trialOlivier Sitbon, Andris Skride, Jeremy Feldman, et al.
Pageof 104